IntroductionGlobally, around 71 million people are chronic hepatitis C (CHC) patients. These infections often become chronic, progressing to cirrhosis, end‐stage liver disease, and hepatocellular carcinoma (HCC). CHC is one of the leading causes of liver transplantation.Chronic hepatitis C patients have been shown to have a higher prevalence of type 2 diabetes mellitus (DM). However, the exact association between the two diseases is not fully understood. This is particularly true in Asians as studies on these populations are scarce. The liver is important for preserving glucose homeostasis, which would be disturbed in liver disorders.Another special feature in Asia–Pacific and some European regions would be coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV), as both infections can be prevalent at the same time in some of these regions. Studies from Spain, Italy, Japan, Taiwan, and Iran reveal that 2% to 25% of CHC patients are also positive for hepatitis B surface antigen (HBsAg). There is well‐established virologic evidence of viral interference in HBV/HCV coinfected patients, yet there are still many gaps in the understanding of the interaction between the two viruses in terms of natural history and response to antiviral treatments.Such a high prevalence of DM and chronic
Journal of Gastroenterology and Hepatology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera